Alcheme Bio
San Diego, US · Founded 2023 · 2 employees on LinkedIn · 2 known investors
Find your way into Alcheme Bio
Sign up to see every warm intro you have to Alcheme Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alcheme Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alcheme Bio develops precision enzyme systems that improve flavor and functionality in protein ingredients during manufacturing processing. The company's enzyme technology reduces off-notes and bitterness in plant proteins, upcycled materials, and emerging protein systems for food manufacturers.
Founders & leadership
VS

Investors · 2
Reported raises · per SEC filings
Form D private placements$118.5K disclosed across 1 round · 2023
▶$118.5KraisedAug 2023 · 8 investors · ManufacturingRule 506(b)
▶$118.5KraisedAug 2023 · 8 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Vanessa SmallExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $118.5K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
AlchemiAlchemi combines AI with scientific expertise to accelerate drug development timelines and reduce time-to-market for therapies. The company serves pharmaceutical development teams and aims to lower drug costs and improve access to medicines.
Alchemy Cloud Inc.Alchemy provides a Product Development Platform including electronic lab notebooks, laboratory information management systems, and artificial intelligence tools that help chemists and material scientists accelerate research, product development, and quality control. The platform integrates with CRM, ERP, and lab equipment systems to digitize core lab processes and improve throughput.
AlkermesAlkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. The company leverages neuroscience expertise to create treatments for patients with complex conditions that are traditionally underserved.
Companies working in the same space as Alcheme Bio.
Frequently asked questions
- What does Alcheme Bio do?
- Alcheme Bio develops precision enzyme systems that improve flavor and functionality in protein ingredients during manufacturing processing. The company's enzyme technology reduces off-notes and bitterness in plant proteins, upcycled materials, and emerging protein systems for food manufacturers.
- Who are Alcheme Bio's investors?
- Alcheme Bio's investors include Big Idea Ventures, How Women Invest.
- How much funding has Alcheme Bio raised?
- Alcheme Bio has disclosed $118.5K raised across 1 round.
- Where is Alcheme Bio headquartered?
- Alcheme Bio is headquartered in San Diego, US.





